Pfizer (BOG:PFECO) Marketable Securities: COP36,973,011 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOG:PFECO Pfizer Inc BOG:PFECO
75 GF Score
Price COP95,840.00
GF Value COP91,518.21
! 8 Warning Signs
View Full Analysis

What is Pfizer Marketable Securities?

Pfizer BOG:PFECO 75 Marketable Securities is COP36,973,011 Mil as of Jun. 2026. GuruFocus rates BOG:PFECO with a GF Score™ of 75/100 and a GF Value™ of COP91,518.21. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pfizer's Marketable Securities for the quarter that ended in Jun. 2026 was COP36,973,011 Mil.

Pfizer's annual Marketable Securities increased from Dec. 2023 (COP38,108,538 Mil) to Dec. 2024 (COP85,617,264 Mil) but then declined from Dec. 2024 (COP85,617,264 Mil) to Dec. 2025 (COP47,046,479 Mil).

Pfizer  (BOG:PFECO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pfizer Marketable Securities Related Terms

Pfizer Marketable Securities Historical Data

* Premium members only.

The historical data trend for Pfizer's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Marketable Securities Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118,538,750.00 108,207,717.66 38,108,538.00 85,617,264.36 47,046,479.48

Pfizer Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47,430,935.00 53,418,428.82 47,046,479.48 41,604,462.00 36,973,011.23
BOG:PFECO
75GF Score
Pfizer Inc BOG:PFECO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of COP36,973,011 Mil mean?
Pfizer (BOG:PFECO) has a Marketable Securities of COP36,973,011 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Pfizer and its competitors.
Is Pfizer's Marketable Securities too high?
Pfizer's current Marketable Securities is COP36,973,011 Mil. Overall, Pfizer has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Marketable Securities compare to GILD and BMY?
Pfizer's Marketable Securities of COP36,973,011 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Pfizer and its competitors. Pfizer's current Marketable Securities is COP36,973,011 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Pfizer (BOG:PFECO) has a current Marketable Securities of COP36,973,011 Mil. The stock's GF Value™ is COP91,518.21, compared to a current price of COP95,840.00 — trading 4.7% above its estimated fair value. The current Marketable Securities is COP36,973,011 Mil. Pfizer's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Pfizer (BOG:PFECO), the current Marketable Securities is COP36,973,011 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (BOG:PFECO) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be overvalued. The current stock price of COP95,840.00 is trading 4.7% above its estimated GF Value™ of COP91,518.21.

Key valuation signals for BOG:PFECO:

  • Marketable Securities: COP36,973,011 Mil
  • GF Value™: COP91,518.21 vs. price of COP95,840.00 (4.7% above fair value)
  • GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the BOG:PFECO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
75GF Score

Get the complete analysis for BOG:PFECO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

COP95,840.00
Price
COP91,518.21
GF Value